Active Pharmaceutical Ingredients - Dr Reddy's
Active Pharmaceutical Ingredients - Dr Reddy's

About Zoledronic Acid API

Product
  • Therapeutic Category Oncology

  • CAS Number

    118072-93-8

  • API Technology

    Synthetic

  • Dose Form

    Injectable

  • Dr Reddy's Development Status

    Available

  • Available Regulatory Filing

    USDMF, CEP Submitted, EUDMF, Russia DMF

Mechanism of Action

Zoledronic acid slows down bone resorption, allowing the bone-forming cells time to rebuild normal bone and allowing bone remodeling

Indication

Reclast is a bisphosphonate indicated for:

  • Treatment and prevention of postmenopausal osteoporosis
  • Treatment to increase bone mass in men with osteoporosis
  • Treatment and prevention of glucocorticoid-induced osteoporosis
  • Treatment of Paget’s disease of bone in men and women

Zometa is a bisphosphonate indicated for the treatment of:

  • Hypercalcemia of malignancy.
  • Patients with multiple myeloma and patients with documented bone metastases from solid tumors, in conjunction with standard antineoplastic therapy. Prostate cancer should have progressed after treatment with at least one hormonal therapy

Request for Quotation

Get in touch with us by filling out the form below. Our team will reach out to you shortly!

Phone
Country *
Select Product *
Select Regulatory Requirements
Select Purpose

Related APIs

ゾレドロン酸

Oncology

arrow

ダサチニブ一水和物

Oncology

arrow

アダグラシブ

Oncology

arrow

ベンダムスチン塩酸塩

Oncology

arrow

フルキンチニブ

Oncology

arrow

ベネトクラクス

Oncology

arrow

ツカチニブ

Oncology

arrow

リプレチニブ

Oncology

arrow

アビラテロン酢酸エステル

Oncology

arrow

アザシチジン

Oncology

arrow

ボルテゾミブ

Oncology

arrow

カバジタキセル

Oncology

arrow

カボザンチニブ塩酸塩

Oncology

arrow

カボザンチニブS-リンゴ酸塩

Oncology

arrow

カペシタビン

Oncology

arrow

カルフィルゾミブ

Oncology

arrow

デシタビン

Oncology

arrow

デュクラバシチニブ

Oncology

arrow

アパルタミド(非晶質およ びB型)

Oncology

arrow

エリブリンメシル酸塩

Oncology

arrow

ゲムシタビン

Oncology

arrow

ロムスチン

Oncology

arrow

ニロチニブ塩酸塩

Oncology

arrow

オラパリブ( A型)

Oncology

arrow

パルボシクリブ(A型)

Oncology

arrow

パゾパニブ

Oncology

arrow

ペメトレキセド二ナトリウム七水和物

Oncology

arrow

ピルトブルチニブ

Oncology

arrow

レルゴリクス

Oncology

arrow

ポマリドミド

Oncology

arrow

アカラブルチニブ

Oncology

arrow

Capivasertib(卡帕塞替尼)

Oncology

arrow

レナリドミド( A型)

Oncology

arrow

ミドスタウリン(非晶質お よびII型)

Oncology

arrow

レンバチニブメシ ル酸塩(C型およびMIBK溶媒和物)

Oncology

arrow

エンザルタミド(結晶およびプレミックス)

Oncology

arrow

免責事項

No information on this website, including any reference to any product or service constitutes an offer for sale or be construed as representing an offer for sale. Products protected under valid patents are not offered or supplied for commercial use. However, in certain cases, at Dr. Reddy's sole discretion, and subject to local legal requirement, the research quantities of such products may be offered for the purpose of regulatory submissions under Section 107A of the Indian Patent Act (Bolar exemption), wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the product or service including, patent scenario in their respective markets and will be responsible for all patent related liabilities Dr. Reddy's disclaims all warranties, express or implied, including but not limited to warranties of merchantability, fitness for a particular purpose and non-infringement.

Disclaimer: Products under patent(s) are offered only for R&D purposes U/S 107A of the Patent Act (Bolar Exemption) and not for commercial sale.